Collaborative Science at the Forefront of PharmaCatalyst 2.0

Signet-IMCD successfully concluded its PharmaCatalyst 2.0 seminar series from 18th –22nd May 2026, bringing together 400+ pharmaceutical R&D professionals across Ahmedabad, Chennai, Bengaluru, and Chandigarh.

The four-city technical series served as a dynamic platform for knowledge sharing, scientific collaboration, and industry engagement focused on the latest advancements in drug delivery systems and formulation innovation. In association with leading partners including Roquette, BASF, DFE Pharma, Innophos, Eastman, Hanns G. Werner, Evonik, , and DuPont, the sessions featured insightful presentations and interactive discussions on specialty excipients and innovative pharmaceutical applications.

PharmaCatalyst 2.0 once again reinforced Signet-IMCD’s commitment to fostering compliance-led innovation, strengthening scientific partnerships, and supporting the evolving needs of the pharmaceutical industry.